Piper Sandler reissued their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Friday morning, Benzinga reports. The firm currently has a $15.00 target price on the biopharmaceutical company’s stock. ARDX has been the topic of a number of other research reports. SVB Leerink began coverage on shares of […]
Wedbush reissued their outperform rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report published on Friday, Benzinga reports. The firm currently has a $15.00 price target on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on ARDX. Citigroup increased their target price on shares of Ardelyx from […]
Piper Sandler restated their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $15.00 price objective on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on the company. StockNews.com cut Ardelyx from a hold […]
Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research note issued to investors on Friday, Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. Wedbush’s price target would indicate a potential upside of 122.22% from the company’s previous close. […]
StockNews.com downgraded shares of Ardelyx (NASDAQ:ARDX – Free Report) from a hold rating to a sell rating in a report published on Tuesday. A number of other equities analysts also recently issued reports on the company. SVB Leerink started coverage on Ardelyx in a report on Friday, April 5th. They issued an outperform rating and […]